Mitessh Thakkar of miteshthacker.com told CNBC-TV18, "HDFC Bank is making new highs and I am slightly positive over there as long as the stock remains above Rs 1,860-1,870 zone which was a difficult breakout zone. I think this is still a buy. I would look at targets close to about Rs 1,950 over here."
"Lot of pharma stocks are showing some reversal today. Lupin is what I picked up as a trading call. Buy with a stop loss at Rs 865 and look for targets close to Rs 920-925 to begin with."
"Larsen & Toubro is an intraday buy with a stop loss at Rs 1,219 for target of Rs 1,260."
"Lupin and Glenmark Pharma are clearly on my list. I think the other one which I like and we had a buy call yesterday was Aurobindo Pharma. The stock has moved up slightly but the momentum is clearly missing, maybe once it breaks Rs 700 I think you will see that kind of momentum come in," he said.
"I do like midcap stock - Alembic Pharma, but disclaimer here I personally hold this stock in my portfolio."
"Lupin is possibly going through a reversal and therefore these are good levels to possibly average keeping stop loss at about Rs 800 but I think eventually this stock could give a medium term reversal which could seek price towards Rs 1,050 which is where you can look for an exit."
"The long term charts of Delta Corp are very exciting, the only advice which I would give is to buy in tranches. So, buy 25 percent here, buy on any 10-15 points dip. Keep on adding 25 percent. Keep a stop loss below Rs 250 odd zones and my sense is that this stock will keep surprising on the upside," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
